405 related articles for article (PubMed ID: 8863083)
1. Adolescents' reasons for and experience after discontinuation of the long-acting contraceptives Depo-Provera and Norplant.
Harel Z; Biro FM; Kollar LM; Rauh JL
J Adolesc Health; 1996 Aug; 19(2):118-23. PubMed ID: 8863083
[TBL] [Abstract][Full Text] [Related]
2. Depo-Provera in adolescents: effects of early second injection or prior oral contraception.
Harel Z; Biro FM; Kollar LM
J Adolesc Health; 1995 May; 16(5):379-84. PubMed ID: 7662688
[TBL] [Abstract][Full Text] [Related]
3. A prospective study of adolescents who choose among levonorgestrel implant (Norplant), medroxyprogesterone acetate (Depo-Provera), or the combined oral contraceptive pill as contraception.
Cromer BA; Smith RD; Blair JM; Dwyer J; Brown RT
Pediatrics; 1994 Nov; 94(5):687-94. PubMed ID: 7936897
[TBL] [Abstract][Full Text] [Related]
4. Long-term depot medroxyprogesterone acetate (Depo-Provera) use in inner-city adolescents.
Polaneczky M; Liblanc M
J Adolesc Health; 1998 Aug; 23(2):81-8. PubMed ID: 9714170
[TBL] [Abstract][Full Text] [Related]
5. Contraception in the adolescent patient.
Tafelski T; Boehm KE
Prim Care; 1995 Mar; 22(1):145-59. PubMed ID: 7777635
[TBL] [Abstract][Full Text] [Related]
6. Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives.
Mainwaring R; Hales HA; Stevenson K; Hatasaka HH; Poulson AM; Jones KP; Peterson CM
Contraception; 1995 Mar; 51(3):149-53. PubMed ID: 7621683
[TBL] [Abstract][Full Text] [Related]
7. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives.
Cromer BA; Blair JM; Mahan JD; Zibners L; Naumovski Z
J Pediatr; 1996 Nov; 129(5):671-6. PubMed ID: 8917232
[TBL] [Abstract][Full Text] [Related]
8. Depo Provera. Position paper on clinical use, effectiveness and side effects.
Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M
Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
[TBL] [Abstract][Full Text] [Related]
9. Adolescents' experience with the combined estrogen and progestin transdermal contraceptive method Ortho Evra.
Harel Z; Riggs S; Vaz R; Flanagan P; Dunn K; Harel D
J Pediatr Adolesc Gynecol; 2005 Apr; 18(2):85-90. PubMed ID: 15897103
[TBL] [Abstract][Full Text] [Related]
10. Depo-Provera and Norplant implants prove no competition for no. 1 choice, OCs. The 1994 pill survey.
American Health Consultants
Contracept Technol Update; 1994 Dec; 15(12):157-61. PubMed ID: 12288903
[TBL] [Abstract][Full Text] [Related]
11. Depo-Provera use in an Australian metropolitan practice.
Fraser IS; Dennerstein GJ
Med J Aust; 1994 May; 160(9):553-6. PubMed ID: 8164553
[TBL] [Abstract][Full Text] [Related]
12. The use of Norplant and Depo Provera in adolescents.
Ammerman SD
J Adolesc Health; 1995 May; 16(5):343-6. PubMed ID: 7662681
[TBL] [Abstract][Full Text] [Related]
13. Introducing more contraceptive methods in Jordan.
Gallagher M
AVSC News; 1998; 36(1):3, 8. PubMed ID: 12321883
[TBL] [Abstract][Full Text] [Related]
14. Acceptability and discontinuation of Depo-Provera, IUCD and combined pill in Kenya.
Sekadde-Kigondu C; Mwathe EG; Ruminjo JK; Nichols D; Katz K; Jessencky K; Liku J
East Afr Med J; 1996 Dec; 73(12):786-94. PubMed ID: 9103686
[TBL] [Abstract][Full Text] [Related]
15. Teens and Depo-Provera: a good match?
Contracept Technol Update; 1995 Jul; 16(7):86-8. PubMed ID: 12346507
[TBL] [Abstract][Full Text] [Related]
16. A comparative study of one-year weight gain among users of medroxyprogesterone acetate, levonorgestrel implants, and oral contraceptives.
Moore LL; Valuck R; McDougall C; Fink W
Contraception; 1995 Oct; 52(4):215-9. PubMed ID: 8605778
[TBL] [Abstract][Full Text] [Related]
17. The use of levonorgestrel implants (Norplant) for contraception in adolescent mothers.
Polaneczky M; Slap G; Forke C; Rappaport A; Sondheimer S
N Engl J Med; 1994 Nov; 331(18):1201-6. PubMed ID: 7935659
[TBL] [Abstract][Full Text] [Related]
18. Determinants of early implant discontinuation among low-income women.
Kalmuss D; Davidson AR; Cushman LF; Heartwell S; Rulin M
Fam Plann Perspect; 1996; 28(6):256-60. PubMed ID: 8959415
[TBL] [Abstract][Full Text] [Related]
19. Ask the experts: progestin-only contraceptives.
Hatcher RA; Schnare S
Contracept Technol Update; 1993 Jul; 14(7):114-5. PubMed ID: 12286999
[TBL] [Abstract][Full Text] [Related]
20. Comparative acceptability of combined and progestin-only injectable contraceptives in Kenya.
Ruminjo JK; Sekadde-Kigondu CB; Karanja JG; Rivera R; Nasution M; Nutley T
Contraception; 2005 Aug; 72(2):138-45. PubMed ID: 16022854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]